Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04201340 · ClinicalTrials.gov registry record
Topcon DRI OCT Triton With SS-OCT Angio Software Evaluation Study
A clinical trial, sponsored by Topcon Corporation.
- Completed
- Registry status
- 211
- Enrollment target
NCT04201340: Completed study, sponsored by Topcon Corporation.
NCT04201340 is a clinical trial that has completed, run by Topcon Corporation. The registered enrollment target is 211 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04201340 has completed, sponsored by Topcon Corporation.
- COMPLETED
- Registry status
- 211 participants
- Enrollment target
Study Summary
Comparisons for vascular structure visualization in the retina and choroid.
Interventions
- DEVICE Cirrus HD-OCT 5000
- DEVICE TRC-50DX
- DEVICE DRI OCT Triton with SS-OCT Angio software
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2019-12-11 |
| Est. Completion | 2022-10-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04201340
The ClinicalTrials.gov registry entry for NCT04201340 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 211 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Topcon Corporation, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cirrus HD-OCT 5000 is the first listed.
NCT04201340 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04201340 about?
NCT04201340 is a clinical study titled "Topcon DRI OCT Triton With SS-OCT Angio Software Evaluation Study". Comparisons for vascular structure visualization in the retina and choroid.
What is the current status of trial NCT04201340?
This trial is currently completed. The enrollment target is 211 participants. The study started on 2019-12-11. Estimated completion is 2022-10-20.
What interventions are being tested in trial NCT04201340?
The interventions under investigation include: Cirrus HD-OCT 5000 (DEVICE), TRC-50DX (DEVICE), DRI OCT Triton with SS-OCT Angio software (DEVICE).
Who is sponsoring clinical trial NCT04201340?
This trial is sponsored by Topcon Corporation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.